Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer

Clinical Cancer Research

Volumn 3, Issue 10, 1997, Pages 1707-1711

  Steinberg, Joseph ^a   Oyasu, Ryoichi ^a   Lang, Sharon ^a   Sintich, Sharon ^a   Rademaker, Alfred ^a   Lee, Chung ^a   Kozlowski, James M ^a   Sensibar, Julia A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN;

APOPTOSIS; ARTICLE; CANCER GRADING; CELL DEATH; CELL LEVEL; CELL PROTECTION; CHROMOSOME 8; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; LIPID TRANSPORT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SERTOLI CELL;

ADENOCARCINOMA; APOPTOSIS; BIOPSY; CARCINOMA IN SITU; CLUSTERIN; DENSITOMETRY; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MOLECULAR CHAPERONES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030843011     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sensibar, J., Sutkowski, D., Raffo, A., Buttyan, R., Griswold, M., Sylvester, S., Kozlowski, J., and Lee, C. Prevention of cell death induced by tumor necrosis factor α in LNCaP cells by overexpression of sulfated glycoprotein 2 (Clusterin). Cancer Res., 55: 2431-2437, 1995.
2. Sylvester, S. R., Skinner, M. K., and Griswold, M. D. A sulphated glycoprotein synthesized by Sertoli cells and by epididymal cells is a component of the cell membrane. Biol. Reprod., 31: 1087-1101, 1984.
3. Koch-Brandt, C., and Morgans, C. Clusterin. A role of cell survival in the face of apoptosis? In: Y. Kuchino and W. E. B. Muller (eds.). Apoptosis, pp. 130-148. Berlin: Springer Verlag, 1996.
4. Rosenberg, M. E., and Silkensen, J. Clusterin. Physiologic and pathophysiologic considerations. Int. J. Biochem. Cell Biol., 27: 633-645, 1995.
5. Lee, C., and Sensibar, J. A. Proteins of the rat prostate II: synthesis of new proteins in the ventral lobe during castration induced regression. J. Urol., 138: 903-908, 1987.
6. Rosenberg, M. Cellular responses to renal injury. Presented at the 10th International Symposium on Cellular Endocrinology: Molecular and Cell Biology of Apoptosis in Development, Disease, and Cancer, held September 29-October 2, 1994 at the W. Alton Jones Cell Science Center, Lake Placid, NY.
7. Swertfeger D. K., Witte, D. P., and Harmony, J. A. K. Cardiac injury induces apolipoprotein J expression in ventricular thymocytes. Presented at The Second Clusterin Workshop, held September 3-5, 1994, in Coeur d'Alene, ID. Abstract no. 7.
8. French, L. E., Sappino, A. P., Tschopp, J., and Schifferli, J. A. Distinct sites of production and deposition of the putative cell death marker Clusterin in the human thymus. J. Clin. Invest., 90: 1919-1925, 1992.
9. Aronow, B. J., Lund, D. S., Brown, T. L., Harmony, J. A. K., and Witte, D. P. Apolipoprotein J expression at fluid-tissue interfaces. Potential role in barrier cytoprotection. Proc. Natl. Acad. Sci. USA, 90: 725-729, 1993.
10. Jordan-Starck, T. C., Witte, D. P., Aronow, B. J., and Harmony, J. A. K. Apolipoprotein J: a membrane policeman? Curr. Opin. Lipidol., 3: 75-85, 1992.
11. Berges, R. R., Vukanovic, J., Epstein, J. I., CarMichel, M., Cisek, L., Johnson, D. E., Veltri, R. W., Walsh, P. C., and Isaacs, J. T. Implication of cell kinetic changes during the progression of human prostatic cancer. Clin. Cancer Res., 1: 473-480, 1995.
12. Denmeade, S. R., Lin, X. S., and Isaacs, J. T. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate, 28: 251-265, 1996.
13. Tu, H., Jacobs, S. C., Borkowski, A., and Kyprianou, N. Incidence of apoptotis and cell proliferation in prostate cancer: relationship with TGF-β and bcl-2 expression. Int. J. Cancer, 69: 357-363, 1996.
14. Parczyk, K., Pilarsky, C., Rachel, U., and Koch-Brandt, C. Gp80 (Clusterin;TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas. J. Cancer Res. Clin. Oncol., 120: 186-188, 1994.
15. Rennie, P. S., Bruchovsky, N., Akakura, K., Goldenberg, S. L., Otal, N., Akakura, S., Wong, P., and Tenniswood, M. Effect of tumour progression on the androgenic regulation and the androgen receptor, TRPM-2 and YPT1 genes in the Shionogi carcinoma. J. Steroid Biochem. Mol. Biol., 50: 31-40, 1994.
16. Kadomatsu, K., Anzano, M., Slayter, M. V., Winokur, T. S., Smith, J. M., and Sporn, M. B. Expression of sulfated glycoprotein 2 is associated with carcinogenesis induced by N-nitroso-N-methylurea in rat prostate and seminal vesicle. Cancer Res., 55: 1480-1483, 1993.
17. Danik, M., Chabot, J-G., Mercier, C., Benabid, A-L., Chauvin, C., Quirion, R., and Suh, M. Human glioma and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death. Proc. Natl. Acad. Sci. USA, 88: 8577-8581, 1991.
18. Bruchovsky, N., Snoek, R., Rennie, P., Akakura, S., Goldenberg, L., and Gleave, M. Control of tumor progression by maintenance of apoptosis. Prostate, 6 (Suppl.): 13-21, 1996.
19. Reddy, K. B., Jin, G., Karode, M. C., Harmony, J. A., and Howe, P. H. Transforming growth factor β (TGF-β)-induced nuclear localization of apolipoprotein J/Clusterin in epithelial cells. Biochemistry, 35: 6157-6163, 1996.
20. Sensibar, J. A., Griswold, M. D., Sylvester, S. R., Buttyan, R., Bardin, C. W., Cheng, C. Y., Dudek, S., and Lee, C. Prostatic ductal system in rats: regional variation in localization of an androgen repressed gene product, sulfated glycoprotein-2. Endocrinology, 128: 2091-2102, 1991.
21. Reed, J. C. Regulation of apoptosis by Bcl-2 family proteins and its role in cancer chemoresistance. Curr. Opin. Oncol., 7: 541-546, 1995.
22. McConkey, D., Greene, G., and Pettaway, C. Apoptosis resistance increases metastatic potential in cells of the human LNCaP prostate carcinoma line. Cancer Res., 56: 5594-5599, 1996.
23. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L., Mao, X., Nunez, G., and Thompson, C. D. Bcl-x, a Bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74: 597-608, 1993.
24. Reynolds, J. E., Yang, T., Qian, L., Jenkinson, J. D., Zhou, P., Eastman, A., and Craig, R. W. Mcl-1, a member of the Bcl-2 family delay apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res., 54: 6348-6352, 1994.
25. Krajewska, M., Stanislaw, K., Epstein, J. I., Shabaik, A., Sauvegeot, J., Song, K., Kitada, S., and Reed, J. C. Immunochemical analysis Bcl-2, Bax, Bcl-x, and Mcl-1 expression in prostate cancers. Am. J. Pathol., 148: 1567-1576, 1996.
26. Columbel, M., Symmans, F., Gil, S., O'Toole, K. M., Chopin, D., Benson, M., Olsson, C. A., Korsmeyer, S., and Buttyan, R. Detection of apoptosis-suppressing oncoprotein bcl-2 in hormone refractory prostate cancers. Am. J. Pathol., 143: 390-399, 1993.
27. McDonnell, T. J., Troncoso, P., Brisbay, S. M., Logothetis, C., Chung, L. W. K., Hsieh, J. T., Tu, S. M., and Campbell, M. L. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52: 6940-6944, 1992.